NEW YORK (GenomeWeb News) – Three Massachusetts research hospitals will evaluate Protein Forest’s bioinformatics software in separate disease studies, the company said Friday.
 
The Whitehead Institute, the Proteomics and Mass Spectrometry Facility at the University of Massachusetts Medical School, and Harvard Medical School will use the company’s Mass Spec Results Analysis Tool (MSRAT) to study data generated using the company’s digital ProteomeChip system.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.